TamiDeniseJohnMD
Pediatric Hematology & Oncology • Palo Alto, CAClinical Associate Professor, Pediatric Stem Cell Transplant and Regenerative Medicine
Dr. John is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
725 Welch Rd
Palo Alto, CA 94304Phone+1 650-497-8000
Education & Training
Baylor College of MedicineFellowship, Pediatric Stem Cell Transplant, 2016 - 2017
University of California (Irvine)/Children's Hospital of Orange CountyFellowship, Pediatric Hematology/Oncology, 2013 - 2016
University of California Davis HealthResidency, Pediatrics, 2010 - 2013
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2010
Certifications & Licensure
CA State Medical License 2011 - 2025
TX State Medical License 2016 - 2023
OR State Medical License 2011 - 2011- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Early Career Clinician Award Baylor, 2021
Publications & Presentations
PubMed
- 6 citationsAllogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma.Tami John, Swati Naik, Kathryn Leung, Ghadir Sasa, Caridad Martinez
Pediatric Transplantation. 2018-08-01 - 5 citationsGlobal perspectives on cellular therapy for children with sickle cell disease.Tami D John, Ruth Namazzi, Lulu Chirande, Venée N Tubman
Current Opinion in Hematology. 2022-11-01 - 4 citationsSickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those...Lakshmanan Krishnamurti, Staci D Arnold, Ann Haight, Allistair Abraham, Gregory Mt Guilcher
JMIR Research Protocols. 2022-07-06
Journal Articles
- Dismantling cost and infrastructure barriers to equitable access to gene therapies for sickle cell diseaseAkshay Sharma, Tami D John, The Lancet Hematology, 7/1/2024
Abstracts/Posters
- Genomic Characterization of a Pediatric Cohort with Non-Malignant Lymphoproliferative DisordersTami D John, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia in the Contemporary EraTami D John, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Myeloablative Conditioning with Alemtuzumab in Matched Related Donor Hematopoietic Cell Transplant for Sickle Cell Disease Prevents Graft-Versus-Host Disease without C...Tami John, ASH annual meeting, 12/1/2019
- Join now to see all
Press Mentions
- Black Teen with Sickle Cell Disease First Gene Therapy Patient at Texas Medical CenterMarch 17th, 2022
- Katy Teen Is the First Texas Medical Center Patient to Receive Gene Therapy for Sickle Cell DiseaseMarch 15th, 2022
- Gene Therapy for Neurologic DiseaseJune 21st, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
